市场调查报告书
商品编码
1518784
全球细胞处理仪器市场 2024-2031Global Cell Processing Instrument Market 2024-2031 |
细胞处理仪器市场规模、份额和趋势分析报告,按类型(细胞计数器、细胞成像系统、流式细胞仪、细胞分离器系统、自动化细胞处理系统和其他仪器)、按应用(细胞分离/分离、细胞影像和计数) 、细胞活力和增殖以及其他应用)以及最终用户(製药和生物技术公司、CRO 和 CMO、学术和研究机构等)预测期 (2024-2031)
预计在预测期内(2024-2031 年)细胞处理仪器市场将以 6.4% 的复合年增长率成长。细胞处理仪器是一种专门的工具,用于操作和製备用于各种目的的细胞,包括细胞疗法、再生医学和疫苗开发。它的重要性在于利用健康细胞来对抗疾病或修復受损组织。
Cell Processing Instrument Market Size, Share & Trends Analysis Report by Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments), by Application (Cell Isolation/Separation, Cell Imaging & Counting, Cell Viability & Proliferation, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, and Others) Forecast Period (2024-2031)
Cell processing instrument market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Cell processing instrument is a specialized tool used to manipulate and prepare cells for various purposes, including cell-based therapies, regenerative medicine, and vaccine development. Its importance lies in utilizing healthy cells to fight diseases or repair damaged tissues.
Market Dynamics
Increasing Government Support
Governments around the world are increasingly recognizing the potential of cell-based therapies and are providing financial support for R&D activities in this area. This support is helping to accelerate the development of new cell therapies and is also creating a more favorable market environment for cell processing instrument manufacturers. For instance, in February 2024, the NIH announced a new $200 million initiative to support research on gene editing for cell-based therapies. This funding will go towards developing safer and more effective gene therapies, which will rely heavily on advanced cell processing instruments.
Technological Advancements
Technological advancements are leading to the development of new and more sophisticated cell processing instruments. These instruments are making it possible to process cells more efficiently and effectively, which is essential for the development of cell-based therapies. For instance, in April 2023 Digitize Designs launched the RM-300 Automated Mobile 3D Scanning Inspection Workstation, a portable and affordable solution for manufacturing. The RM-300 integrates with the assembly line, making metrology and part inspection more accessible and eliminating common errors.
Market Segmentation
Cell Separator Systems is Projected to Emerge as the Largest Segment
The increasing demand for cell-based therapies and technological advancements in cell separator systems is a key contributor to the high share of this market segment. The increasing prevalence of chronic diseases and the role cell separators play in these therapies underscore the importance of these technologies.
However, the cell processing systems sub-segment is expected to grow over the coming years. Technological advancements in robotics, automation, and integration will enhance these systems' functionality and user-friendliness. Microfluidic cell processing systems, an emerging technology, offer advantages such as miniaturization, cost-effectiveness, precise control, and rapid prototyping and experimentation. They are attractive for small labs and point-of-care applications, with high growth potential driven by scalability needs.
The global cell processing instrument market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Holds Major Market Share
Among all the regions, North America holds a significant share of the global market. The presence of robust healthcare infrastructure, favorable regulatory environments, and high investments in R&D related to biotechnology are major contributors to the regional market share. Major manufacturers like Thermo Fisher Scientific and Danaher Corporation are headquartered in North America, allowing for faster innovation and market adaptation. The concept of personalized medicine is also gaining traction, further stimulating the cell processing instrument market across the region.
The major companies serving the global cell processing instrument market include Agilent Technologies Inc., Danaher Corp., Thermo Scientific Inc., Merck KGaA, and Beckman Coulter, Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May 2023, BD announced the commercial launch of BD FACSDiscover S8 Cell Sorter, a first-of-its-kind that uses a high-speed cell imaging system. Thus, this instrument features two technologies, which would enable researchers to understand cells more precisely and effectively.